.
.
Pierre Souverain from Pfizer (L) with acting Director General of RBC Claver Kayumba. Pfizer, an International Pharmaceutical company, held a three-day workshop to discuss strategies of how counterfeit drugs can be combated. The New Times/ J. Mbanda